NKX2-1 and cancer: Importantly, we show that PSPH is essential for the proliferation of NKX2–1 expressing cancer cells, and we uncover that NKX2–1 overexpressing cells are sensitised to metabolic drugs, including the dual SHMT1/2 inhibitor sertraline and the topoisomerase II inhibitor etoposide.